Integrated Organ Immunity: Antigen-specific CD4-T cell-derived IFN-γ induced by BCG imprints prolonged lung innate resistance against respiratory viruses
A. Lee, K. Floyd, S.-Y. Wu, Z. Fang, T. K. Tan, C. Li, H. Hui, D. Scoville, A. Ruggiero, Y. Liang, A. Pavenko, V. Lujan, G. P. Nolan, P. Arunachalam, M. Suthar, B. Pulendran
Abstract
Bacille Calmette-Guerin (BCG) vaccination can confer non-specific protection against heterologous pathogens. However, the underlying mechanisms remain mysterious. Here, we show that mice immunized intravenously with BCG exhibited reduced weight loss and/or improved viral clearance when challenged with SARS-CoV-2 and influenza. Protection was first evident between 14 - 21 days post vaccination, and lasted for at least 42 days. Remarkably, BCG induced a biphasic innate response in the lung, initially at day 1 and a subsequent prolonged phase starting at [~]15 days post vaccination, and robust antigen-specific Th1 responses. MyD88-dependent TLR signaling was essential for the induction of the innate and Th1 responses, and protection against SARS-CoV-2. Depletion of CD4+ T cells or IFN-{gamma} activity prior to infection obliterated innate activation and protection. Single cell and spatial transcriptomics revealed CD4-dependent expression of interferon-stimulated genes (ISGs) in myeloid, type II alveolar and lung epithelial cells. Thus, BCG elicits "integrated organ immunity" where CD4+ T cells act on local myeloid and epithelial cells to imprint prolonged antiviral innate resistance.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
K. L. Hilligan, S. Namasivayam, … A. Sher·bioRxiv·Aug 30, 2021
- Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2
K. L. Hilligan, S. Namasivayam, … A. Sher·bioRxiv·Jul 15, 2023
- Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung
- Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation
A. K. Singh, R. Wang, … W. Bishai·bioRxiv·Mar 15, 2022
- Protective intravenous BCG vaccination induces enhanced immune signaling in the airways
J. M. Peters, E. B. Irvine, … B. D. Bryson·bioRxiv·Jul 16, 2023
- Intravenous BCG induces a more potent airway and lung immune response than intradermal BCG in SIV-infected macaques
Solomon Jauro, Erica C. Larson, … Charles A. Scanga·The Journal of ImmunologyPeer-reviewed·Sep 23, 2024